These results indicate that compound 15y is a novel, highly potent TBK1 inhibitor with predominant bioactivity and is predicted to be a promising tool compound that is helpful to understand functions of targeting TBK1 in immune response and cancer therapy. This evidence concerns the gene TBK1 and cancer.